Johnson & Johnson reached a potential $5.5 billion settlement on Monday in an effort to settle past legal woes over claims that its talc products were behind cases of ovarian cancer. The settlement would cover roughly 76,000 claims with no cap on payouts. Johnson & Johnson said it plans to issue the first round of…
